[English] 日本語
Yorodumi Papers
- Database of articles cited by EMDB/PDB/SASBDB data -

+
Search query

Keywords
Structure methods
Author
Journal
IF

-
Structure paper

TitleA humanized yeast proteasome identifies unique binding modes of inhibitors for the immunosubunit beta 5i.
Journal, issue, pagesEMBO J., Vol. 35, Page 2602-2613, Year 2016
Publish dateMay 27, 2016 (structure data deposition date)
AuthorsHuber, E.M. / Heinemeyer, W. / de Bruin, G. / Overkleeft, H.S. / Groll, M.
External linksEMBO J. / PubMed:27789522
MethodsX-ray diffraction
Resolution2.4 - 2.9 Å
Structure data

PDB-5l52:
Yeast 20S proteasome in complex with epoxyketone inhibitor 14
Method: X-RAY DIFFRACTION / Resolution: 2.7 Å

PDB-5l54:
Yeast 20S proteasome in complex with epoxyketone inhibitor 16
Method: X-RAY DIFFRACTION / Resolution: 2.8 Å

PDB-5l55:
Yeast 20S proteasome in complex with epoxyketone inhibitor 18
Method: X-RAY DIFFRACTION / Resolution: 2.9 Å

PDB-5l5a:
Yeast 20S proteasome with human beta5i (1-138; R57T)
Method: X-RAY DIFFRACTION / Resolution: 2.4 Å

PDB-5l5b:
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133)
Method: X-RAY DIFFRACTION / Resolution: 2.8 Å

PDB-5l5d:
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with ONX 0914
Method: X-RAY DIFFRACTION / Resolution: 2.8 Å

PDB-5l5e:
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib
Method: X-RAY DIFFRACTION / Resolution: 2.9 Å

PDB-5l5f:
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib
Method: X-RAY DIFFRACTION / Resolution: 2.5 Å

PDB-5l5h:
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with PR-924
Method: X-RAY DIFFRACTION / Resolution: 2.6 Å

PDB-5l5i:
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9
Method: X-RAY DIFFRACTION / Resolution: 2.9 Å

PDB-5l5j:
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14
Method: X-RAY DIFFRACTION / Resolution: 2.9 Å

PDB-5l5o:
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
Method: X-RAY DIFFRACTION / Resolution: 2.6 Å

PDB-5l5p:
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
Method: X-RAY DIFFRACTION / Resolution: 2.8 Å

PDB-5l5q:
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18
Method: X-RAY DIFFRACTION / Resolution: 2.8 Å

PDB-5l5r:
Yeast 20S proteasome with human beta5i (1-138;V31M) and human beta6 (97-111; 118-133)
Method: X-RAY DIFFRACTION / Resolution: 2.9 Å

PDB-5l5s:
Yeast 20S proteasome with human beta5i (1-138; V31M) and human beta6 (97-111; 118-133) in complex with PR-924
Method: X-RAY DIFFRACTION / Resolution: 2.6 Å

PDB-5l5t:
Yeast 20S proteasome with human beta5i (1-138; V31M) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
Method: X-RAY DIFFRACTION / Resolution: 2.9 Å

PDB-5l5u:
Yeast 20S proteasome with human beta5i (1-138; V31M) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
Method: X-RAY DIFFRACTION / Resolution: 2.6 Å

PDB-5l5v:
'Yeast 20S proteasome with human beta5i (1-138; V31M) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
Method: X-RAY DIFFRACTION / Resolution: 2.7 Å

PDB-5l5w:
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133)
Method: X-RAY DIFFRACTION / Resolution: 2.8 Å

PDB-5l5x:
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with ONX 0914
Method: X-RAY DIFFRACTION / Resolution: 2.9 Å

PDB-5l5y:
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib
Method: X-RAY DIFFRACTION / Resolution: 2.7 Å

PDB-5l5z:
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib
Method: X-RAY DIFFRACTION / Resolution: 2.7 Å

PDB-5l60:
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with PR-924
Method: X-RAY DIFFRACTION / Resolution: 2.7 Å

PDB-5l61:
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14
Method: X-RAY DIFFRACTION / Resolution: 2.8 Å

PDB-5l62:
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
Method: X-RAY DIFFRACTION / Resolution: 2.8 Å

PDB-5l63:
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
Method: X-RAY DIFFRACTION / Resolution: 2.7 Å

PDB-5l64:
Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
Method: X-RAY DIFFRACTION / Resolution: 2.7 Å

PDB-5l65:
Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib
Method: X-RAY DIFFRACTION / Resolution: 2.9 Å

PDB-5l66:
Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib
Method: X-RAY DIFFRACTION / Resolution: 2.8 Å

PDB-5l67:
Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with PR-924
Method: X-RAY DIFFRACTION / Resolution: 2.6 Å

PDB-5l68:
Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14
Method: X-RAY DIFFRACTION / Resolution: 2.8 Å

PDB-5l69:
Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
Method: X-RAY DIFFRACTION / Resolution: 2.7 Å

PDB-5l6a:
Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
Method: X-RAY DIFFRACTION / Resolution: 2.8 Å

PDB-5l6b:
Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with ONX 0914
Method: X-RAY DIFFRACTION / Resolution: 2.6 Å

PDB-5l6c:
Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
Method: X-RAY DIFFRACTION / Resolution: 2.6 Å

PDB-5ltt:
Yeast 20S proteasome with human beta5i (1-138; R57T)in complex with PR-924
Method: X-RAY DIFFRACTION / Resolution: 2.7 Å

Chemicals

ChemComp-MG:
Unknown entry

ChemComp-CL:
Unknown entry

ChemComp-6N5:
~{N}-[(2~{S})-1-[[(2~{S})-3-(4-methoxyphenyl)-1-[[(2~{S},3~{S},4~{R})-4-methyl-3,5-bis(oxidanyl)-1-phenyl-pentan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-propan-2-yl]-1-methyl-5~{H}-indene-2-carboxamide

ChemComp-MES:
2-(N-MORPHOLINO)-ETHANESULFONIC ACID / pH buffer*YM

ChemComp-HOH:
WATER

ChemComp-79P:
(2~{S})-3-(1~{H}-indol-3-yl)-~{N}-[(2~{S},3~{S},4~{R})-4-methyl-3,5-bis(oxidanyl)-1-phenyl-pentan-2-yl]-2-[[(2~{R})-2-(2-morpholin-4-ylethanoylamino)propanoyl]amino]propanamide

ChemComp-6NV:
~{N}-[(2~{R})-1-[[(2~{S})-3-(4-methoxyphenyl)-1-[[(2~{S},3~{S},4~{R})-4-methyl-3,5-bis(oxidanyl)-1-phenyl-pentan-2-yl]amino]-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-propan-2-yl]-1-methyl-5~{H}-indene-2-carboxamide

ChemComp-04C:
1,2,4-trideoxy-4-methyl-2-{[N-(morpholin-4-ylacetyl)-L-alanyl-O-methyl-L-tyrosyl]amino}-1-phenyl-D-xylitol

ChemComp-3BV:
N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-L-phenylalaninamide / medication, anticancer, inhibitor*YM

ChemComp-BO2:
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE / medication, anticancer*YM

ChemComp-39V:
N-[(3-methyl-1H-inden-2-yl)carbonyl]-D-alanyl-N-[(2S,4R)-5-hydroxy-4-methyl-3-oxo-1-phenylpentan-2-yl]-L-tryptophanamide

ChemComp-38X:
N-[(3-methyl-1H-inden-2-yl)carbonyl]-D-alanyl-N-[(2S,4R)-1-cyclohexyl-5-hydroxy-4-methyl-3-oxopentan-2-yl]-L-tryptophanamide

ChemComp-79L:
(2~{S})-3-(4-methoxyphenyl)-~{N}-[(2~{S},3~{S},4~{R})-4-methyl-3,5-bis(oxidanyl)-1-phenyl-pentan-2-yl]-2-[[(2~{R})-2-(2-morpholin-4-ylethanoylamino)propanoyl]amino]propanamide

Source
  • saccharomyces cerevisiae s288c (yeast)
  • saccharomyces cerevisiae (strain atcc 204508 / s288c) (yeast)
  • homo sapiens (human)
  • saccharomyces cerevisiae (brewer's yeast)
  • mus musculus (house mouse)
KeywordsHYDROLASE/HYDROLASE INHIBITOR / HYDROLASE-HYDROLASE INHIBITOR complex / Proteasome / Inhibitor / Binding Analysis / HYDROLASE complex / Mutant

+
About Yorodumi Papers

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi Papers

Database of articles cited by EMDB/PDB/SASBDB data

  • Database of articles cited by EMDB, PDB, and SASBDB entries
  • Using PubMed data

Related info.:EMDB / PDB / SASBDB / Yorodumi / EMN Papers / Changes in new EM Navigator and Yorodumi

Read more